Trial Profile
Phase I Trial of Pbi-shRNA EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Bi shRNAEWS-FLI-Type-1-LPX (Primary)
- Indications Ewing's sarcoma
- Focus Adverse reactions
- Sponsors Gradalis; Strike Bio
- 14 Jul 2023 Status changed from active, no longer recruiting to completed.
- 17 Apr 2023 Planned primary completion date changed from 1 Jan 2023 to 1 Jun 2023.
- 14 Mar 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.